Results 151 to 160 of about 62,613 (194)

The Choice of ADRs

SSRN Electronic Journal, 2008
Abstract We study the determinants of a firm’s decision to issue one of the four available ADR programs (Level I, Level II, Level III, and Rule 144A). We find that the firm’s attributes (size, income, asset growth, leverage, privatization, ownership structure, and country-of-origin) and the firm’s home-country institutional variables (accounting ...
Narjess Boubakri, Jean-Claude Cosset, Anis Samet   +2 more
openaire   +1 more source

ADR

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1949
  +8 more sources

ADR

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1946
  +6 more sources

ADR

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1947
  +5 more sources

For ADR counsel: A spotlight on ADR use

Alternatives to the High Cost of Litigation, 1996
Michael E. Bragg, Richard W. Simmons
openaire   +1 more source

Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring

Clinical Gastroenterology and Hepatology, 2021
Tonya Kaltenbach, Craig S Meyer, Samir Gupta   +2 more
exaly  

ADR

2023
openaire   +1 more source

The effects and mechanisms of aloe‐emodin on reversing adriamycin‐induced resistance of MCF‐7/ADR cells

Phytotherapy Research, 2021
Zifeng Pi, Zhong Zheng, Shu Liu
exaly  

ADR

Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1951
  +4 more sources

Adenoma and Serrated Lesion Detection by Colonoscopy Indication: The ADR-ESS (ADR Extended to all Screening/Surveillance) Score

Clinical Gastroenterology and Hepatology, 2021
Uri Ladabaum, Ajitha Mannalithara
exaly